Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.85 USD | -0.40% |
|
-0.20% | +1.30% |
Jun. 09 | Nature's Sunshine Products files for offering of 2.8 mln shares | RE |
Jun. 02 | Terrence Moorehead to Step Down as Chief Executive Officer of Nature?s Sunshine Products, Inc | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 385M | 444M | 422M | 445M | 454M | |||||
Total Revenues | 385M | 444M | 422M | 445M | 454M | |||||
Cost of Goods Sold, Total | 101M | 115M | 122M | 124M | 130M | |||||
Gross Profit | 284M | 329M | 300M | 321M | 325M | |||||
Selling General & Admin Expenses, Total | 262M | 294M | 284M | 297M | 305M | |||||
Other Operating Expenses, Total | 262M | 294M | 284M | 297M | 305M | |||||
Operating Income | 21.48M | 34.67M | 16.26M | 24.45M | 20.1M | |||||
Interest Expense, Total | -102K | -250K | -249K | -69K | -146K | |||||
Interest And Investment Income | 56K | 361K | - | 412K | 177K | |||||
Net Interest Expenses | -46K | 111K | -249K | 343K | 31K | |||||
Currency Exchange Gains (Loss) | 1.27M | -3.06M | -917K | 970K | -1.7M | |||||
Other Non Operating Income (Expenses) | - | - | 283K | - | - | |||||
EBT, Excl. Unusual Items | 22.71M | 31.72M | 15.38M | 25.76M | 18.43M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 115K | 105K | -160K | 140K | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | -5.7M | - | |||||
EBT, Incl. Unusual Items | 22.82M | 31.82M | 15.22M | 20.2M | 18.43M | |||||
Income Tax Expense | -137K | 1.62M | 14.66M | 3.79M | 10.53M | |||||
Earnings From Continuing Operations | 22.96M | 30.21M | 550K | 16.42M | 7.89M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 22.96M | 30.21M | 550K | 16.42M | 7.89M | |||||
Minority Interest | -1.62M | -1.35M | -940K | -1.34M | -196K | |||||
Net Income - (IS) | 21.34M | 28.85M | -390K | 15.08M | 7.7M | |||||
Net Income to Common Incl Extra Items | 21.34M | 28.85M | -390K | 15.08M | 7.7M | |||||
Net Income to Common Excl. Extra Items | 21.34M | 28.85M | -390K | 15.08M | 7.7M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.09 | 1.45 | -0.02 | 0.79 | 0.41 | |||||
Basic EPS - Continuing Operations | 1.09 | 1.45 | -0.02 | 0.79 | 0.41 | |||||
Basic Weighted Average Shares Outstanding | 19.54M | 19.86M | 19.33M | 19.07M | 18.62M | |||||
Net EPS - Diluted | 1.07 | 1.42 | -0.02 | 0.77 | 0.4 | |||||
Diluted EPS - Continuing Operations | 1.07 | 1.42 | -0.02 | 0.77 | 0.4 | |||||
Diluted Weighted Average Shares Outstanding | 19.97M | 20.33M | 19.33M | 19.47M | 19.09M | |||||
Normalized Basic EPS | 0.64 | 0.93 | 0.45 | 0.77 | 0.61 | |||||
Normalized Diluted EPS | 0.63 | 0.91 | 0.45 | 0.76 | 0.59 | |||||
Dividend Per Share | - | - | - | - | - | |||||
Payout Ratio | - | 68.82 | - | - | - | |||||
Supplemental Items | ||||||||||
EBITDA | 32.22M | 45.83M | 27.28M | 36.26M | 34.31M | |||||
EBITA | 21.48M | 34.67M | 16.26M | 24.45M | 20.1M | |||||
EBIT | 21.48M | 34.67M | 16.26M | 24.45M | 20.1M | |||||
EBITDAR | 39.22M | 52.43M | 33.78M | 42.46M | 40.81M | |||||
Effective Tax Rate - (Ratio) | -0.6 | 5.08 | 96.39 | 18.74 | 57.17 | |||||
Current Domestic Taxes | -909K | 54K | -46K | 2.24M | 1.88M | |||||
Current Foreign Taxes | 5.13M | 5.69M | 6.72M | 9.6M | 10.31M | |||||
Total Current Taxes | 4.22M | 5.74M | 6.68M | 11.84M | 12.2M | |||||
Deferred Domestic Taxes | -2.28M | -5.53M | 5.78M | -8.77M | -2.81M | |||||
Deferred Foreign Taxes | -2.08M | 1.4M | 2.21M | 712K | 1.15M | |||||
Total Deferred Taxes | -4.36M | -4.13M | 7.99M | -8.06M | -1.66M | |||||
Normalized Net Income | 12.57M | 18.47M | 8.67M | 14.76M | 11.32M | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.8M | 8.2M | 11M | 11.5M | 13.9M | |||||
Selling and Marketing Expenses | 133M | 148M | 141M | 147M | 154M | |||||
Research And Development Expense From Footnotes | 1.5M | 1.4M | 1.5M | 1.6M | 1.7M | |||||
Net Rental Expense, Total | 7M | 6.6M | 6.5M | 6.2M | 6.5M | |||||
Imputed Operating Lease Interest Expense | 216K | 535K | 614K | 201K | 521K | |||||
Imputed Operating Lease Depreciation | 6.78M | 6.06M | 5.89M | 6M | 5.98M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 4.7M | 3.6M | 1M | - | - | |||||
Stock-Based Comp., Other (Total) | - | - | - | 4.89M | 4.79M | |||||
Total Stock-Based Compensation | 4.7M | 3.6M | 1M | 4.89M | 4.79M |
Select your edition
All financial news and data tailored to specific country editions